Ludwig Institute for Cancer Research, Brussels Branch and de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Curr Opin Immunol. 2012 Feb;24(1):84-91. doi: 10.1016/j.coi.2011.12.002. Epub 2011 Dec 27.
Protein degradation by the proteasome releases peptides that can be loaded on MHC class I molecules and presented to cytolytic T lymphocytes. Several mechanisms were recently found to increase the diversity of antigenic peptides displayed at the cell surface, thereby maximizing the efficacy of immune responses. The proteasome was shown to produce spliced antigenic peptides, which are made of two fragments initially not contiguous in the parental protein. Different proteasome subtypes also produce distinct sets of antigenic peptides: the standard proteasome and the immunoproteasome, containing different catalytic subunits, have different cleavage specificities and produce different sets of peptides. Moreover, recent work confirmed the existence of two additional proteasome subtypes that are intermediate between the standard and the immunoproteasome, and each produce a unique peptide repertoire.
蛋白酶体通过蛋白降解释放出可以加载到 MHC Ⅰ类分子上并呈递给细胞毒性 T 淋巴细胞的肽段。最近发现了几种能够增加细胞表面呈递的抗原肽多样性的机制,从而最大程度地提高免疫反应的效果。蛋白酶体被证明可以产生拼接的抗原肽,这些肽由最初在亲本蛋白中不连续的两个片段组成。不同的蛋白酶体亚型也会产生不同的抗原肽集:标准蛋白酶体和免疫蛋白酶体,含有不同的催化亚基,具有不同的切割特异性,并产生不同的肽集。此外,最近的工作证实了存在两种介于标准蛋白酶体和免疫蛋白酶体之间的额外的蛋白酶体亚型,它们各自产生独特的肽库。